These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22706009)

  • 21. Early treatment of HIV: implications for resource-limited settings.
    Hobbs CV; Essajee SM
    Curr Opin HIV AIDS; 2009 May; 4(3):222-31. PubMed ID: 19532054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twenty-five years of translational medicine in antiretroviral therapy: promises to keep.
    Broder S
    Sci Transl Med; 2010 Jul; 2(39):39ps33. PubMed ID: 20610849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scaling up antiretroviral therapy in resource-limited settings: adapting guidance to meet the challenges.
    Vitoria M; Vella S; Ford N
    Curr Opin HIV AIDS; 2013 Jan; 8(1):12-8. PubMed ID: 23188179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretroviral therapy in HIV.
    Yu A; Berbari E; Temesgen Z
    J Med Liban; 2006; 54(2):74-9. PubMed ID: 17086997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethical and programmatic challenges in antiretroviral scaling-up in Malawi: challenges in meeting the World Health Organization's "Treating 3 million by 2005" initiative goals.
    Muula AS
    Croat Med J; 2004 Aug; 45(4):415-21. PubMed ID: 15311413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance.
    Wensing AM; van Maarseveen NM; Nijhuis M
    Antiviral Res; 2010 Jan; 85(1):59-74. PubMed ID: 19853627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world.
    Bennett DE
    Curr Opin Infect Dis; 2006 Dec; 19(6):607-14. PubMed ID: 17075338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The social construction of ARVs in South Africa.
    Sember R
    Glob Public Health; 2008; 3 Suppl 2():58-75. PubMed ID: 19288353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The discovery and development of HIV therapy: the new challenges.
    Perno CF
    Ann Ist Super Sanita; 2011; 47(1):41-3. PubMed ID: 21430337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settings.
    Bartlett JA; Hornberger J; Shewade A; Bhor M; Rajagopalan R
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(4):253-68. PubMed ID: 19721103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of HIV in resource limited settings.
    McCutchan JA
    Curr Opin Infect Dis; 2009 Oct; 22(5):464-70. PubMed ID: 19730283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-associated neurocognitive disorders: a historical review.
    Rosca EC; Rosca O; Simu M; Chirileanu RD
    Neurologist; 2012 Mar; 18(2):64-7. PubMed ID: 22367830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. User fees and access to ARV treatment for persons living with HIV/AIDS: implementation and challenges in Burkina Faso, a limited-resource country.
    Kouanda S; Bocoum FY; Doulougou B; Bila B; Yameogo M; Sanou MJ; Sawadogo M; Sondo B; Msellati P; Desclaux A
    AIDS Care; 2010 Sep; 22(9):1146-52. PubMed ID: 20824567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The first postmodern pandemic: 25 years of HIV/ AIDS.
    Kallings LO
    J Intern Med; 2008 Mar; 263(3):218-43. PubMed ID: 18205765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989-2009).
    de Béthune MP
    Antiviral Res; 2010 Jan; 85(1):75-90. PubMed ID: 19781578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Nothing new": responses to the introduction of antiretroviral drugs in South Africa.
    Chopra M; Kendall C; Hill Z; Schaay N; Nkonki LL; Doherty TM
    AIDS; 2006 Oct; 20(15):1975-7. PubMed ID: 16988520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatment.
    Kline MW
    Pediatrics; 2006 Apr; 117(4):1388-93. PubMed ID: 16585337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.